Oramorph (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Oramorph, is an opioid analgesic presented as a strength/form for oral use. It is used to treat moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oramorph is an opioid analgesic that acts on the central nervous system to relieve pain.

- Acute postoperative pain: provides rapid relief of pain following surgery. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Severe chronic pain: used when long‑term opioid therapy is required for conditions such as severe musculoskeletal pain.

Side effects vary with dose and individual sensitivity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea and vomiting: stimulation of the chemoreceptor trigger zone. - Drowsiness: central nervous system depression. - Dry mouth: decreased salivary secretion. - Sweating: autonomic activation. - Itching: histamine release.

Serious or Rare Side Effects: - Respiratory depression: reduced drive to breathe. - Hypotension: vasodilation and decreased cardiac output. - Severe allergic reactions: rash, angioedema, anaphylaxis. - Dependence and withdrawal: physical and psychological dependence with abrupt discontinuation. - Urinary retention: difficulty emptying the bladder. - Sedation progressing to coma coma.

When using Oramorph, several important safety considerations should be observed.

- Assess pain severity: ensure opioid therapy is appropriate. - Monitor respiratory function: watch for signs of respiratory depression. - Evaluate renal and hepatic function: dose may need adjustment in impairment. - Avoid concurrent CNS depressants: increased risk of sedation and respiratory depression. - Educate patients on constipation management: use laxatives or stool softeners as needed. - Store at below 25°C: keep in the original packaging, protect  from  ").

The       

t   t   """"  " " " """""""""""""""""""""""""""""""""""""""""""""""""""""""""""

"""  """"""""""